Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-01 4:15 pm Purchase | 2025-09-29 | 13G | BioXcel Therapeutics, Inc. BTAI | Integrated Core Strategies (US) LLC | 1,028,053 5.200% | 1,028,053 (New Position) | Filing History |
| 2025-05-15 4:15 pm Sale | 2025-03-31 | 13G | BioXcel Therapeutics, Inc. BTAI | Oaktree Capital Group Holdings GP LLC | 170,230 2.730% | -25 (-0.01%) | Filing History |
| 2025-05-15 3:33 pm Sale | 2025-03-31 | 13G | BioXcel Therapeutics, Inc. BTAI | Armistice Capital, LLC | 288,131 4.990% | -4,709,144 (-94.23%) | Filing History |
| 2025-02-14 5:27 pm Purchase | 2024-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | Armistice Capital, LLC | 4,997,275 9.990% | 4,997,275 (New Position) | Filing History |
| 2024-12-18 8:19 pm Purchase | 2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI | Oaktree Capital Group Holdings GP LLC | 170,255 5.200% | 170,255 (New Position) | Filing History |
| 2024-12-18 5:20 pm Purchase | 2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI | Qatar Investment Authority | 170,255 5.200% | 170,255 (New Position) | Filing History |
| 2024-09-10 10:47 am Sale | 2024-09-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 67,208 2.639% | -90,203 (-57.30%) | Filing History |
| 2024-06-06 8:29 pm Sale | 2024-06-06 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 551,914 23.500% | -42,126 (-7.09%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 157,410 8.603% | -11,385 (-6.74%) | Filing History |
| 2024-02-07 07:27 am Sale | 2023-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 29,086 1.550% | -67,701 (-69.95%) | Filing History |
| 2023-10-19 4:48 pm Unchanged | 2023-09-19 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 556,359 30.100% | 0 (Unchanged) | Filing History |
| 2023-10-13 4:01 pm Sale | 2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 168,795 9.227% | -93,919 (-35.75%) | Filing History |
| 2023-10-10 09:09 am Purchase | 2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FIL Ltd | 168,795 9.227% | 168,795 (New Position) | Filing History |
| 2023-09-28 5:00 pm Sale | 2023-09-19 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 594,040 32.500% | -15,823 (-2.59%) | Filing History |
| 2023-04-04 06:00 am Sale | 2023-04-03 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 556,359 30.300% | -34,395 (-5.82%) | Filing History |
| 2023-02-14 4:36 pm Purchase | 2022-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 590,755 32.700% | 8,376 (+1.44%) | Filing History |
| 2023-02-13 7:09 pm Sale | 2023-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI | AllianceBernstein L.P. | 2,471 0.100% | -90,627 (-97.35%) | Filing History |
| 2023-02-09 09:02 am Sale | 2023-01-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BlackRock Inc. BLK | 82,025 4.700% | -9,407 (-10.29%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | BioXcel Therapeutics, Inc. BTAI | FMR LLC | 262,715 14.999% | 399 (+0.15%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BlackRock Inc. BLK | 91,433 5.200% | 91,433 (New Position) | Filing History |